Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C28H34O8 |
| Molecular Weight | 498.5648 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1=C(OCCCCCOC2=CC3=C(CCC(O3)C(O)=O)C=C2C(C)=O)C=CC(C(C)=O)=C1O
InChI
InChIKey=FGGYJWZYDAROFF-UHFFFAOYSA-N
InChI=1S/C28H34O8/c1-4-8-21-23(12-10-20(17(2)29)27(21)31)34-13-6-5-7-14-35-26-16-25-19(15-22(26)18(3)30)9-11-24(36-25)28(32)33/h10,12,15-16,24,31H,4-9,11,13-14H2,1-3H3,(H,32,33)
| Molecular Formula | C28H34O8 |
| Molecular Weight | 498.5648 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Ablukast is a benzopyran derivative, a leukotriene receptor antagonist with potential as an antiasthmatic agent. Ablukast antagonized he hypotensive effect of N-methyl leukotriene C4 and leukotriene C4 (LTC4). Ablukast also antagonized the effects induced by high doses of leukotriene D4 and E4. Receptors that preferentially bind LTC4 in bullfrog vascular smooth muscle regulate the hypotensive effect and that they can be antagonized by ablukast. Ablukast has been in phase III clinical trials for the treatment of bowel disease. However, this research has been discontinued.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:26:08 GMT 2025
by
admin
on
Mon Mar 31 18:26:08 GMT 2025
|
| Record UNII |
000TKM5BBQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29712
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20869277
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
C053877
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
100000082325
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
6441
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
57109
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
SUB07363MIG
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
CHEMBL22016
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
AA-71
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
C74132
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
000TKM5BBQ
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
96566-25-5
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY | |||
|
ABLUKAST
Created by
admin on Mon Mar 31 18:26:08 GMT 2025 , Edited by admin on Mon Mar 31 18:26:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER | |||
|
|
RACEMATE -> ENANTIOMER | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |